CXC chemokines regulate angiogenic activity in acute lung injury

Chest

Volumn 116, Issue SUPPL., 1999, Pages 93S-94S

  Keane, Michael P ^b   Wilke, Carol A ^b   Burdick, Marie D ^b   Morris, Susan B ^b   Glass, Mary C ^b   Strieter, Robert M ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; MACROPHAGE INFLAMMATORY PROTEIN 2;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; LUNG FIBROSIS; LUNG INJURY; MESENCHYME CELL; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0032808303     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.suppl_1.93S     Document Type: Conference Paper

References (12)

1. Katzenstein AA, Bloor CM, Liebow AA. Diffuse alveolar damage-role of oxygen, shock and related factors. Am J Pathol 1976; 85:210-222
2. Corrin B. Diffuse alveolar damage. In: Evans TW, Haslett C, eds. ARDS: acute respiratory distress syndrome. London, UK: Chapman & Hall Medical, 1996; 37-46
3. Tomashefski JF. Pulmonary pathology of the adult respiratory distress syndrome. Clin Chest Med 1990; 11:593-619
4. Bitterman PB. Pathogenesis of fibrosis in acute lung injury. Am J Med 1992; 92(suppl 6A):39S-43S
5. Peters JI, Bell RC, Prihoda TJ, et al. Clinical determinants of abnormalities in pulmonary functions in survivors of the adult respiratory distress syndrome. Am Rev Respir Dis 1989; 139:1163-1168
6. McHugh LG, Milberg JA, Whitcomb ME, et al. Recovery of function in survivors of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1994; 150:90-94
7. Suchyta MR, Clemmer TP, Elliott CG, et al. The adult respiratory distress syndrome: a report of survival and modifying factors. Chest 1992; 101:1074-1079
8. Strieter RM, Polverini PJ, Kunkel SL, et al. The functional role of the 'ELR' motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995; 270:27348-27357
9. Arenberg DA, Kunkel SL, Polverini PJ, et al. Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med 1996; 184:981-992
10. Keane MP, Arenberg DA, Lynch JP, et al. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997; 159:1437-1443
11. Baker CC, Chaudry IH, Gaines HO, et al. Evaluation of factors affecting mortality rate after sepsis in a murine cecal Iigation an puncture model. Surgery 1983; 94:331-335
12. Thrall RS, Phan SH, McCormick JR, et al. The development of bleomycin-induced pulmonary fibrosis in neutrophil-depleted and complement-depleted rats. Am J Pathol 1981; 105:76-81